Business Parks & Science Centres

 
 
 

Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px
Organisation › Details

C4 Therapeutics Inc. (C4T)

C4 Therapeutics is developing a new class of targeted protein degradation (TPD) therapeutics for the treatment of a broad range of diseases. Our Degronimid™ platform incorporates highly selective small molecule binders to target disease-causing proteins and facilitate their rapid destruction and clearance from the cell through the natural ubiquitin/proteasome system (UPS). Because of this distinctive mechanism, Degronimids are capable of hitting many more targets, including those previously thought to be undruggable, while reducing the potential for drug resistance. The broad applicability of Degronimids, and our chemical biology platform designed for accelerated validation, have the potential to make an unprecedented impact across many diseases through multiple industry collaborations as well as proprietary programs. *

 

Period Start 2015-01-01 splitoff
  Predecessor Dana-Farber Cancer Institute
Products Industry Degronimid™ platform technology (targeted protein degradation, TPD)
  Industry 2 drug discovery
Person Person Fisherman, Jason (C4 Therapeutics 201601– CEO before Synthesis Capital + Advent International)
     
  Street 490 Arsenal Way
  City 02472 Watertown, MA
  Tel +1-617-231-0700
    Address record changed: 2019-03-19
     
Basic data Employees n. a.
     
    * Document for �About Section�: C4 Therapeutics, Inc.. (1/7/16). "Press Release: C4 Therapeutics Enters Strategic Drug Discovery Collaboration with Roche Pharma in the Promising New Field of Targeted Protein Degradation". Cambridge, MA.
     
   
Record changed: 2019-03-19

Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

More documents for C4 Therapeutics Inc. (C4T)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px




» top